Skip to content
E152 - Therapeutic Guidelines Diabetes episode artwork

Dec 4, 2023 16 min

E152 - Therapeutic Guidelines Diabetes

from Australian Prescriber Podcast

SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

E152 - Therapeutic Guidelines Diabetes

0:00 16:38

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Australian Prescriber Podcast?

This episode is 16 minutes long.

When was this Australian Prescriber Podcast episode published?

This episode was published on December 4, 2023.

Can I download this Australian Prescriber Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.